These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27785577)

  • 21. The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings.
    Wimo A; Reed CC; Dodel R; Belger M; Jones RW; Happich M; Argimon JM; Bruno G; Novick D; Vellas B; Haro JM
    J Alzheimers Dis; 2013; 36(2):385-99. PubMed ID: 23629588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The economic costs of dementia in Korea, 2002.
    Suh GH; Knapp M; Kang CJ
    Int J Geriatr Psychiatry; 2006 Aug; 21(8):722-8. PubMed ID: 16858741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care.
    Behrens S; Rattinger GB; Schwartz S; Matyi J; Sanders C; DeBerard MS; Lyketsos CG; Tschanz JT
    Int Psychogeriatr; 2018 Oct; 30(10):1499-1507. PubMed ID: 29559029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costs of dementia in Hungary.
    Érsek K; Kovács T; Wimo A; Kárpati K; Brodszky V; Péntek M; Jönsson L; Gustavsson A; McDaid D; Kenigsberg PA; Valtonen H; Gulácsi L
    J Nutr Health Aging; 2010 Oct; 14(8):633-9. PubMed ID: 20922339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost of multiple sclerosis in the Czech Republic: the COMS study.
    Blahova Dusankova J; Kalincik T; Dolezal T; Kobelt G; Havrdova E
    Mult Scler; 2012 May; 18(5):662-8. PubMed ID: 21965424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Costs and resource use of community-dwelling patients with Alzheimer's disease in Japan: 18-month results from the GERAS-J study.
    Nakanishi M; Igarashi A; Ueda K; Brnabic AJM; Matsumura T; Meguro K; Yamada M; Mimura M; Arai H; Treuer T
    Curr Med Res Opin; 2021 Aug; 37(8):1331-1339. PubMed ID: 33904362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic Impact of Dementia by Disease Severity: Exploring the Relationship between Stage of Dementia and Cost of Care in Taiwan.
    Ku LJ; Pai MC; Shih PY
    PLoS One; 2016; 11(2):e0148779. PubMed ID: 26859891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A break-even analysis for dementia care collaboration: Partners in Dementia Care.
    Morgan RO; Bass DM; Judge KS; Liu CF; Wilson N; Snow AL; Pirraglia P; Garcia-Maldonado M; Raia P; Fouladi NN; Kunik ME
    J Gen Intern Med; 2015 Jun; 30(6):804-9. PubMed ID: 25666216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The social and economic burden on family caregivers for older adults in the Czech Republic.
    Maresova P; Lee S; Fadeyi OO; Kuca K
    BMC Geriatr; 2020 May; 20(1):171. PubMed ID: 32393190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive cost of illness of dementia in Japan: a time trend analysis based on Japanese official statistics.
    Hanaoka S; Matsumoto K; Kitazawa T; Fujita S; Seto K; Hasegawa T
    Int J Qual Health Care; 2019 Apr; 31(3):231-237. PubMed ID: 30272131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Costs of the in-home patients affected by dementia.
    Isaia G; M Bo ; Nobili G; Cappa G; Mondino S; Pilon S; Massaia M
    Arch Gerontol Geriatr; 2009; 49 Suppl 1():147-51. PubMed ID: 19836628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic cost of dementia patients according to the limitation of the activities of daily living in Korea.
    Kang IO; Lee SY; Kim SY; Park CY
    Int J Geriatr Psychiatry; 2007 Jul; 22(7):675-81. PubMed ID: 17171741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost of Dementia and Its Correlation With Dependence.
    Åkerborg Ö; Lang A; Wimo A; Sköldunger A; Fratiglioni L; Gaudig M; Rosenlund M
    J Aging Health; 2016 Dec; 28(8):1448-1464. PubMed ID: 26818587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cost of dementia in an unequal country: The case of Chile.
    Hojman DA; Duarte F; Ruiz-Tagle J; Budnich M; Delgado C; Slachevsky A
    PLoS One; 2017; 12(3):e0172204. PubMed ID: 28267795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating the economic and social costs of dementia in Ireland.
    Connolly S; Gillespie P; O'Shea E; Cahill S; Pierce M
    Dementia (London); 2014 Jan; 13(1):5-22. PubMed ID: 24381036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost of dementia in Switzerland.
    Kraft E; Marti M; Werner S; Sommer H
    Swiss Med Wkly; 2010; 140():w13093. PubMed ID: 22250014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Healthcare resource utilization and cost in dementia: are there differences between patients screened positive for dementia with and those without a formal diagnosis of dementia in primary care in Germany?
    Michalowsky B; Eichler T; Thyrian JR; Hertel J; Wucherer D; Hoffmann W; Flessa S
    Int Psychogeriatr; 2016 Mar; 28(3):359-69. PubMed ID: 26446797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct and indirect cost of managing alzheimer's disease and related dementias in the United States.
    Deb A; Thornton JD; Sambamoorthi U; Innes K
    Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):189-202. PubMed ID: 28351177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost evaluation of a coordinated care management intervention for dementia.
    Duru OK; Ettner SL; Vassar SD; Chodosh J; Vickrey BG
    Am J Manag Care; 2009 Aug; 15(8):521-8. PubMed ID: 19670955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Costs of multiple sclerosis - extrapolation of Czech data to Polish patients.
    Szmurło D; Fundament T; Ziobro M; Kruntorádová K; Doležal T; Głogowski C
    Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):451-8. PubMed ID: 24702130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.